NPI: 1982644332 · FRONT ROYAL, VA 22630 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,866 | $63K |
| 2019 | 13,092 | $123K |
| 2020 | 11,128 | $134K |
| 2021 | 10,338 | $134K |
| 2022 | 7,057 | $225K |
| 2023 | 2,584 | $210K |
| 2024 | 1,542 | $109K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,733 | 1,294 | $959K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,034 | 701 | $20K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 316 | 171 | $14K |
| J1756 | Injection, iron sucrose, 1 mg | 2,775 | 650 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,340 | 615 | $1K |
| 82728 | 837 | 512 | $184.29 | |
| 83970 | 414 | 280 | $173.17 | |
| 83550 | 826 | 506 | $108.09 | |
| 83540 | 831 | 506 | $79.76 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 53 | 30 | $27.56 |
| 85041 | 656 | 442 | $24.31 | |
| 85048 | 677 | 453 | $21.06 | |
| G0008 | Administration of influenza virus vaccine | 39 | 26 | $10.97 |
| 90674 | 18 | 13 | $4.48 | |
| A4657 | Syringe, with or without needle, each | 3,058 | 989 | $2.45 |